alpha-1a antagonists (Merck & Co)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namealpha-1a antagonists (Merck & Co)
Drug Alias NameBPH therapeutics (Merck & Co)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-1a adrenergic receptor antagonists
TargetsAlpha-1a adrenergic receptor
Therapy Area/IndicationsProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsProstatic Hyperplasia

Other Information

ATC CodeN/A
Related LinksN/A